HuGE Literature Finder
Records
1
-
30
| Genotype-Guided Dual Antiplatelet Therapy in Minor Stroke or Transient Ischemic Attack With a Single Small Subcortical Infarction. Neurology 2023 1 . Liu Huihui, Jing Jing, Wang Anxin, Xu Qin, Meng Xia, Li Hao, Li Zixiao, Wang Yongj |
| Influence of CYP2C19 genetic variants and smoking on dual antiplatelet efficacy in patients with coronary artery disease. Frontiers in cardiovascular medicine 2023 2 10 1105001. Cheng Yujing, Sun Yan, Zhang Dai, Ma Xiaoteng, Liu Chi, Hu Chengping, Sun Tienan, Zhao Ziwei, Liu Xiaoli, Zhou Yuj |
| Relationship between CYP2C19*2, *3 gene polymorphism and the recurrence in ischemic stroke patients treated with clopidogrel in China: A meta-analysis. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2022 Nov 31 (11): 106798. Yan Yu, Hao Ruixiao, Zhao Xiuyuan, Xia Xiaoshuang, Wang Lin, Li X |
| Association of CYP2C19 Polymorphism With Proton Pump Inhibitors Effectiveness and With Fractures in Real-Life: Retrospective Cohort Study. Clinical pharmacology and therapeutics 2022 Feb . Gronich Naomi, Lavi Idit, Lejbkowicz Flavio, Pinchev Mila, Rennert G |
| CYP2C19 polymorphisms and clopidogrel efficacy in the secondary prevention of ischemic stroke: a retrospective observational study. Annals of palliative medicine 2022 1 10 (12): 12171-12180. Lin Juanna, Mo You, Cai De, Mao Dongyang, Fu Hongbo, Wei Dunc |
| Development and Validation of a Novel Tool for the Prediction of Clopidogrel Response in Chinese Acute Coronary Syndrome Patients: The GeneFA Score. Frontiers in pharmacology 2022 4 13 854867. Wu Hongyi, Li Xiaoye, Qian Juying, Zhao Xin, Yao Yao, Lv Qianzhou, Ge Jun |
| P2Y12 Reaction Units and Clinical Outcomes in Acute Large Artery Atherosclerotic Stroke: A Multicenter Prospective Study. Journal of atherosclerosis and thrombosis 2022 3 30 (1): 39-55. Fukuma Kazuki, Yamagami Hiroshi, Ihara Masafumi, Tanaka Tomotaka, Miyata Toshiyuki, Miyata Shigeki, Kokame Koichi, Nishimura Kunihiro, Nakaoku Yuriko, Yamamoto Haruko, Hayakawa Mikito, Kamiyama Kenji, Enomoto Yukiko, Itabashi Ryo, Furui Eisuke, Manabe Yasuhiro, Ezura Masayuki, Todo Kenichi, Hashikawa Kazuo, Uchiyama Shinichiro, Toyoda Kazunori, Nagatsuka Kazuyu |
| Application of Age, Body Mass Index, Chronic Kidney Disease, Diabetes, and Genotyping Score for Efficacy of Clopidogrel: Secondary Analysis of the CHANCE Trial. Stroke 2021 Oct STROKEAHA120033049. Dai Liye, Xu Jie, Yan Hongyi, Chen Zimo, Pan Yuesong, Meng Xia, Li Hao, Wang Yongj |
| Risk of stroke in CYP2C19 LoF polymorphism carrier coronary artery disease patients undergoing clopidogrel therapy: An ethnicity-based updated meta-analysis. European journal of internal medicine 2021 Jun . Jafrin Sarah, Naznin Nura Ershad, Reza Md Sharif, Aziz Md Abdul, Islam Mohammad Safiq |
| Cost-effectiveness of CYP2C19 genotyping to guide antiplatelet therapy for acute minor stroke and high-risk transient ischemic attack. Scientific reports 2021 Apr 11 (1): 7383. Cai Zeling, Cai De, Wang Ruiwen, Wang Heng, Yu Ze, Gao Fei, Liu Yuansheng, Kang Yingbo, Wu Zhuom |
| Effect of CYP2C19 genotypes on tamoxifen metabolism and early-breast cancer relapse. Scientific reports 2021 Jan 11 (1): 415. Sanchez-Spitman A B, Swen J J, Dezentjé V O, Moes D J A R, Gelderblom H, Guchelaar H |
| Enriching Medication Review with a Pharmacogenetic Profile - A Case of Tamoxifen Adverse Drug Reactions. Pharmacogenomics and personalized medicine 2021 14 279-286. Jeiziner Chiara, Stäuble Céline K, Lampert Markus L, Hersberger Kurt E, Meyer Zu Schwabedissen Henriette |
| Increase in the risk of clopidogrel resistance and consequent TIMI flow impairment by DNA hypomethylation of CYP2C19 gene in STEMI patients undergoing primary percutaneous coronary intervention (PPCI). Pharmacology research & perspectives 2021 2 9 (2): e00738. Sukmawan Renan, Hoetama Erick, Suridanda Danny Siska, Giantini Astuti, Listiyaningsih Erlin, Gilang Rejeki Vidya, Aziz Alkatiri Amir, Firdaus Ism |
| Association between CYP2C19 gene polymorphisms and lipid metabolism in Chinese patients with ischemic stroke. The Journal of international medical research 2020 Jul 48 (7): 300060520934657. Bai Yunxue, Huang Ruicheng, Wan Lagen, Zhao R |
| The correlation between recurrent risk and CYP2C19 gene polymorphisms in patients with ischemic stroke treated with clopidogrel for prevention. Medicine 2020 3 99 (11): e19143. Liu Guohua, Yang Sufang, Chen Siq |
| Efficacy of clopidogrel for stroke depends on CYP2C19 genotype and risk profile. Annals of neurology 2019 Jun . Xu Jie, Wang Anxin, Wangqin Runqi, Mo Jinglin, Chen Zimo, Dai Liye, Meng Xia, Zhao Xingquan, Wang Yilong, Li Hao, Chen Wei, Xian Ying, Wang Yongjun, |
| Influence of smoking on CYP2C19 genetic variants and clopidogrel efficacy in patients with minor stroke or transient ischaemic attack. European journal of neurology 2019 Apr . Wang T, Pan Y, Lin J, Anand R, Wang D, Johnston S C, Meng X, Li H, Zhao X, Liu L, Wang Y, Wang Y, |
| Association Between ABCB1 Polymorphisms and Outcomes of Clopidogrel Treatment in Patients With Minor Stroke or Transient Ischemic Attack: Secondary Analysis of a Randomized Clinical Trial. JAMA neurology 2019 Feb . Pan Yuesong, Chen Weiqi, Wang Yilong, Li Hao, Johnston S Claiborne, Simon Tabassome, Zhao Xingquan, Liu Liping, Wang David, Meng Xia, Wang Yongjun, |
| Effects of MAO-A and CYP450 on primaquine metabolism in healthy volunteers. Parasitology research 2019 2 118 (3): 1011-1018. Ariffin Norliza Mat, Islahudin Farida, Kumolosasi Endang, Makmor-Bakry Mo |
| Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial. BMJ (Clinical research ed.) 2019 6 365 l2211. Wang Yilong, Chen Weiqi, Lin Yi, Meng Xia, Chen Guohua, Wang Zhimin, Wu Jialing, Wang Dali, Li Jianhua, Cao Yibin, Xu Yuming, Zhang Guohua, Li Xiaobo, Pan Yuesong, Li Hao, Zhao Xingquan, Liu Liping, Lin Jinxi, Dong Kehui, Jing Jing, Johnston S Claiborne, Wang David, Wang Yongjun, |
| Association of CYP2C19*2 and ALDH1A1*1/*2 variants with disease outcome in breast cancer patients: results of a global screening array. European journal of clinical pharmacology 2018 Jun . Kalra Sourav, Kaur Raman Preet, Ludhiadch Abhilash, Shafi Gowhar, Vashista Rajesh, Kumar Raj, Munshi Anja |
| CYP2C19 and ABCB1 genetic polymorphisms correlate with the recurrence of ischemic cardiovascular adverse events after clopidogrel treatment. Journal of clinical laboratory analysis 2018 Jun 32 (5): e22369. Hou Xumin, Han Wenzheng, Gan Qian, Liu Yuan, Fang Wei |
| Association of N6AMT1 rs2254638 Polymorphism With Clopidogrel Response in Chinese Patients With Coronary Artery Disease. Frontiers in pharmacology 2018 10 9 1039. Li He, Zhang Yan-Jiao, Li Mu-Peng, Hu Xiao-Lei, Song Pei-Yuan, Peng Li-Ming, Ma Qi-Lin, Tang Jie, Zhang Wei, Chen Xiao-Pi |
| Effects of Triflusal and Clopidogrel on the Secondary Prevention of Stroke Based on Cytochrome P450 2C19 Genotyping. Journal of stroke 2017 Sep 19 (3): 356-364. Han Sang Won, Kim Yong-Jae, Ahn Seong Hwan, Seo Woo-Keun, Yu Sungwook, Oh Seung-Hun, Nam Hyo Suk, Choi Hye-Yeon, Yoon Sung Sang, Kim Seo Hyun, Lee Jong Yun, Lee Jun Hong, Hwang Yang-Ha, Lee Kee Ook, Jung Yo Han, Lee Jun, Sohn Sung-Il, Kim Youn Nam, Lee Kyung-A, Bushnell Cheryl D, Lee Kyung-Y |
| CYP2C19*2 and CYP2C19*17 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium dataset. Scientific reports 2017 Aug 7 (1): 7727. Damkier Per, Kjærsgaard Anders, Barker Kimberly A, Cronin-Fenton Deidre, Crawford Anatasha, Hellberg Ylva, Janssen Emilius A M, Langefeld Carl, Ahern Thomas P, Lash Timothy |
| Impact of Glycemic Control on Efficacy of Clopidogrel in Transient Ischemic Attack or Minor Stroke Patients With CYP2C19 Genetic Variants. Stroke 2017 Mar . Lin Yi, Wang Anxin, Li Jiejie, Lin Jinxi, Wang David, Meng Xia, Ou Lixian, Chen Weiqi, Zhao Xingquan, Liu Liping, Wang Yilong, Wang Yongj |
| The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics. Cardiology research and practice 2017 2017 8062796. Amin Arwa M, Sheau Chin Lim, Azri Mohamed Noor Dzul, Sk Abdul Kader Muhamad Ali, Kah Hay Yuen, Ibrahim Baharud |
| Impact of genetic polymorphisms related to clopidogrel or acetylsalicylic acid pharmacology on clinical outcome in Chinese patients with symptomatic extracranial or intracranial stenosis. European journal of clinical pharmacology 2016 Oct 72 (10): 1195-1204. Zhao Zhigang, Li Xingang, Sun Shusen, Mei Shenghui, Ma Ning, Miao Zhongrong, Zhao Ming, Peng Shi |
| Genotype Frequencies of CYP2C19, P2Y12 and GPIIIa Polymorphisms in Coronary Heart Disease Patients of Han Ethnicity, and Their Impact on Clopidogrel Responsiveness. International heart journal 2016 Sep 57 (5): 586-92. Ou Wenchao, He Yongcong, Li Aiqun, Liu Benrong, Jin Lij |
| Interaction of CYP2C19, P2Y12, and GPIIIa Variants Associates With Efficacy of Clopidogrel and Adverse Events on Patients With Ischemic Stroke. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2016 May . Yi Xingyang, Wang Yanfen, Lin Jing, Cheng Wen, Zhou Qiang, Wang Ch |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: